Mumps outbreaks reported across the country

… an increase from last year when only 154 cases were reported in the state, according to the Washington State Health Department. In Tulsa, Okla., officials are investigating five confirmed cases of mumps in the area, KFOR-TV reported. And in …

John Ross Breaks NFL Combine 40-Yard Dash Record With 4.22 Seconds

Former University of Washington wide receiver John Ross broke Chris Johnson’s NFL Combine 40-year dash record today with a lightning fast time of 4.22 seconds, beating out CJ2K’s 2008 run by two-hundredths of a second. The 2016 AP Pac-12 Player of the Year said of his record-breaking run: I’m just thankful beyond measure, blessed, and just really happy to be in this situation.

Smartphones are revolutionizing medicine

… are turning to smartphones for use in their daily work, seeing them as a useful tool for managing electronic health data and figuring out the most effective clinical trials, said Gregory Hager, professor of computer science at Johns Hopkins …

Smartphones are revolutionizing medicine

… are turning to smartphones for use in their daily work, seeing them as a useful tool for managing electronic health data and figuring out the most effective clinical trials, said Gregory Hager, professor of computer science at Johns Hopkins …

Research suggests the stem cells in our teeth can be energized to fill in chips, cracks, and cavities

The stem cells in our teeth can be energized to fill in chips, cracks, and cavities, researchers say, and the findings could one day possibly make dental cement obsolete. The work has been conducted just in mice so far, but the research , published Monday in the journal Scientific Reports, highlights a way to motivate stem cells to repair tooth defects at a scale they normally can’t, with a drug that already has some safety testing behind it.

Study compares medications for treatment of persons with recurrent genital herpes

In a study appearing in the December 20 issue of JAMA , Anna Wald, M.D., M.P.H., of the University of Washington & Fred Hutchinson Cancer Research Center, Seattle, and colleagues compared the medications pritelivir and valacyclovir for reducing genital herpes simplex virus shedding and lesions in persons with recurrent genital herpes. The treatment for genital herpes simplex virus infections relies on the nucleoside analogues acyclovir, valacyclovir, or famciclovir administered either for each recurrence or daily to prevent recurrences.